MoneyWorks4Me

Dr. Reddy’s Laboratories submits press release

28 Nov 2024 Evaluate

Dr. Reddy’s Laboratories has submitted a Press Release on “Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.”

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1748.00
Dr. Reddys Labs. 1309.00
Cipla 1344.10
Lupin 1930.05
Zydus Lifesciences 1144.50
View more..